The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Chodon, Thinle
One or more keywords matched the following items that are connected to Chodon, Thinle
Item TypeName
Concept Immunotherapy
Concept Immunotherapy, Adoptive
Concept Immunotherapy, Active
Academic Article MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro.
Academic Article Active Immunotherapy of Cancer.
Academic Article Adoptive transfer of MART-1 T-cell receptor transgenic lymphocytes and dendritic cell vaccination in patients with metastatic melanoma.
Academic Article The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Academic Article Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer.
Academic Article Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapy.
Academic Article HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
Academic Article Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products.
Academic Article Cellular Immunotherapy in the Treatment of Hematopoietic Malignancies.
Academic Article The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy.
Academic Article Emerging Role and Future Directions of Immunotherapy in Advanced Ovarian Cancer.
Academic Article BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapy.
Academic Article A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma.
Academic Article Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses.
Academic Article Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM?CAIX in immunocompetent mouse models.
Search Criteria
  • Immunotherapy